Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials
2014-01-01 Santoni, M; Conti, A; De Giorgi, U; Iacovelli, R; Pantano, F; Burattini, L; Muzzonigro, G; Berardi, R; Santini, D; Cascinu, S
Cell-free DNA as a diagnostic marker for cancer: current insights
2016-01-01 Salvi, S; Gurioli, G; De Giorgi, U; Conteduca, V; Tedaldi, G; Calistri, D; Casadio, V
Clinical pharmacology of intraperitoneal cisplatin-based chemotherapy.
2004-01-01 Conti, M; De Giorgi, U; Tazzari, V; Bezzi, F; Baccini, C
Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line
2006-01-01 Vrekoussis, T; Stathopoulos, En; De Giorgi, U; Kafousi, M; Pavlaki, K; Kalogeraki, A; Chrysos, E; Fiorentini, G; Zoras, O
Outcome of patients with renal cell carcinoma and multiple glandular metastases treated with targeted agents
2017-01-01 Grassi, P; Doucet, L; Giglione, P; Grünwald, V; Melichar, B; Galli, L; De Giorgi, U; Sabbatini, R; Ortega, C; Santoni, M; Bamias, A; Verzoni, E; Derosa, L; Studentova, H; Porcu, L; De Braud, F; Porta, C; Procopio, G
Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients?
2006-01-01 De Giorgi, U
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study
2016-01-01 D'Aniello, C; Vitale, Mg; Farnesi, A; Calvetti, L; Laterza, Mm; Cavaliere, C; Della Pepa, C; Conteduca, V; Crispo, A; De Vita, F; Grillone, F; Ricevuto, E; De Tursi, M; De Vivo, R; Di Napoli, M; Cecere, Sc; Iovane, G; Amore, A; Piscitelli, R; Quarto, G; Pisconti, S; Ciliberto, G; Maiolino, P; Muto, P; Perdonà, S; Berretta, M; Naglieri, E; Galli, L; Cartenì, G; De Giorgi, U; Pignata, S; Facchini, G; Rossetti, S
Caregiver emotional burden in testicular cancer patients: From patient to caregiver support
2019-01-01 De Padova, S.; Casadei, C.; Berardi, A.; Bertelli, T.; Filograna, A.; Cursano, M. C.; Menna, C.; Burgio, S. L.; Altavilla, A.; Schepisi, G.; Prati, S.; Montalti, S.; Chovanec, M.; Banna, G. L.; Grassi, L.; Mego, M.; De Giorgi, U.
Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient
2003-01-01 Ciucci, G; De Giorgi, U; Leoni, M; Bianchedi, G.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
2019-01-01 Rini, Bi; Powles, T; Atkins, Mb; Escudier, B; Mcdermott, Df; Suarez, C; Bracarda, S; Stadler, Wm; Donskov, F; Lee, Jl; Hawkins, R; Ravaud, A; Alekseev, B; Staehler, M; Uemura, M; De Giorgi, U; Mellado, B; Porta, C; Melichar, B; Gurney, H; Bedke, J; Choueiri, Tk; Parnis, F; Khaznadar, T; Thobhani, A; Li, S; Piault-Louis, E; Frantz, G; Huseni, M; Schiff, C; Green, Mc; Motzer, Rj
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
2017-01-01 Mego, M; Gao, H; Cohen, En; Anfossi, S; Giordano, A; Tin, S; Fouad, Tm; De Giorgi, U; Giuliano, M; Woodward, Wa; Alvarez, Rh; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M; Reuben, Jm
The potential use of urine cell free DNA as a marker for cancer
2016-01-01 Salvi, S; Martignano, F; Molinari, C; Gurioli, G; Calistri, D; De Giorgi, U; Conteduca, V; Casadio, V
Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: need of guidelines for catheter positioning, port management, and anti-coagulant therapy
2001-01-01 Fiorentini, G; De Giorgi, U; Giovanis, P; Guadagni, S; Cantore, M; Marangolo, M
Vitamin D status among long-term survivors of testicular cancer
2017-01-01 Schepisi, G; De Padova, S; Scarpi, E; Lolli, C; Gurioli, G; Menna, C; Burgio, Sl; Rossi, L; Gallà, V; Casadio, V; Salvi, S; Conteduca, V; De Giorgi, U
Glaucoma and paclitaxel
2000-01-01 De Giorgi, U; Acciarri, R; Fiorentini, G; Rosti, G; Marangolo, M
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
2015-01-01 Salvi, S; Casadio, V; Conteduca, V; Burgio, Sl; Menna, C; Bianchi, E; Rossi, L; Carretta, E; Masini, C; Amadori, D; Calistri, D; Attard, G; De Giorgi, U
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
2014-01-01 Motzer, Rj; Porta, C; Vogelzang, Nj; Sternberg, Cn; Szczylik, C; Zolnierek, J; Kollmannsberger, C; Rha, Sy; Bjarnason, Ga; Melichar, B; De Giorgi, U; Grünwald, V; Davis, Id; Lee, Jl; Esteban, E; Urbanowitz, G; Cai, C; Squires, M; Marker, M; Shi, Mm; Escudier, B.
Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?
2008-01-01 De Giorgi, U; Perkins, Gh; Cristofanilli, M.
Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7
2018-01-01 De Giorgi, U; Conteduca, V; Scarpi, E
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity
2001-01-01 Bacci, G; Ferrari, S; Tienghi, A; Bertoni, F; Mercuri, M; Longhi, A; Fiorentini, G; Forni, C; Bacchini, P; Rimondini, S; De Giorgi, U; Picci, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials | 1-gen-2014 | Santoni, M; Conti, A; De Giorgi, U; Iacovelli, R; Pantano, F; Burattini, L; Muzzonigro, G; Berardi, R; Santini, D; Cascinu, S | |
| Cell-free DNA as a diagnostic marker for cancer: current insights | 1-gen-2016 | Salvi, S; Gurioli, G; De Giorgi, U; Conteduca, V; Tedaldi, G; Calistri, D; Casadio, V | |
| Clinical pharmacology of intraperitoneal cisplatin-based chemotherapy. | 1-gen-2004 | Conti, M; De Giorgi, U; Tazzari, V; Bezzi, F; Baccini, C | |
| Modulation of vascular endothelium by imatinib: a study on the EA.hy 926 endothelial cell line | 1-gen-2006 | Vrekoussis, T; Stathopoulos, En; De Giorgi, U; Kafousi, M; Pavlaki, K; Kalogeraki, A; Chrysos, E; Fiorentini, G; Zoras, O | |
| Outcome of patients with renal cell carcinoma and multiple glandular metastases treated with targeted agents | 1-gen-2017 | Grassi, P; Doucet, L; Giglione, P; Grünwald, V; Melichar, B; Galli, L; De Giorgi, U; Sabbatini, R; Ortega, C; Santoni, M; Bamias, A; Verzoni, E; Derosa, L; Studentova, H; Porcu, L; De Braud, F; Porta, C; Procopio, G | |
| Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients? | 1-gen-2006 | De Giorgi, U | |
| Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study | 1-gen-2016 | D'Aniello, C; Vitale, Mg; Farnesi, A; Calvetti, L; Laterza, Mm; Cavaliere, C; Della Pepa, C; Conteduca, V; Crispo, A; De Vita, F; Grillone, F; Ricevuto, E; De Tursi, M; De Vivo, R; Di Napoli, M; Cecere, Sc; Iovane, G; Amore, A; Piscitelli, R; Quarto, G; Pisconti, S; Ciliberto, G; Maiolino, P; Muto, P; Perdonà, S; Berretta, M; Naglieri, E; Galli, L; Cartenì, G; De Giorgi, U; Pignata, S; Facchini, G; Rossetti, S | |
| Caregiver emotional burden in testicular cancer patients: From patient to caregiver support | 1-gen-2019 | De Padova, S.; Casadei, C.; Berardi, A.; Bertelli, T.; Filograna, A.; Cursano, M. C.; Menna, C.; Burgio, S. L.; Altavilla, A.; Schepisi, G.; Prati, S.; Montalti, S.; Chovanec, M.; Banna, G. L.; Grassi, L.; Mego, M.; De Giorgi, U. | |
| Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient | 1-gen-2003 | Ciucci, G; De Giorgi, U; Leoni, M; Bianchedi, G. | |
| Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. | 1-gen-2019 | Rini, Bi; Powles, T; Atkins, Mb; Escudier, B; Mcdermott, Df; Suarez, C; Bracarda, S; Stadler, Wm; Donskov, F; Lee, Jl; Hawkins, R; Ravaud, A; Alekseev, B; Staehler, M; Uemura, M; De Giorgi, U; Mellado, B; Porta, C; Melichar, B; Gurney, H; Bedke, J; Choueiri, Tk; Parnis, F; Khaznadar, T; Thobhani, A; Li, S; Piault-Louis, E; Frantz, G; Huseni, M; Schiff, C; Green, Mc; Motzer, Rj | |
| Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer | 1-gen-2017 | Mego, M; Gao, H; Cohen, En; Anfossi, S; Giordano, A; Tin, S; Fouad, Tm; De Giorgi, U; Giuliano, M; Woodward, Wa; Alvarez, Rh; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M; Reuben, Jm | |
| The potential use of urine cell free DNA as a marker for cancer | 1-gen-2016 | Salvi, S; Martignano, F; Molinari, C; Gurioli, G; Calistri, D; De Giorgi, U; Conteduca, V; Casadio, V | |
| Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: need of guidelines for catheter positioning, port management, and anti-coagulant therapy | 1-gen-2001 | Fiorentini, G; De Giorgi, U; Giovanis, P; Guadagni, S; Cantore, M; Marangolo, M | |
| Vitamin D status among long-term survivors of testicular cancer | 1-gen-2017 | Schepisi, G; De Padova, S; Scarpi, E; Lolli, C; Gurioli, G; Menna, C; Burgio, Sl; Rossi, L; Gallà, V; Casadio, V; Salvi, S; Conteduca, V; De Giorgi, U | |
| Glaucoma and paclitaxel | 1-gen-2000 | De Giorgi, U; Acciarri, R; Fiorentini, G; Rosti, G; Marangolo, M | |
| Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone | 1-gen-2015 | Salvi, S; Casadio, V; Conteduca, V; Burgio, Sl; Menna, C; Bianchi, E; Rossi, L; Carretta, E; Masini, C; Amadori, D; Calistri, D; Attard, G; De Giorgi, U | |
| Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial | 1-gen-2014 | Motzer, Rj; Porta, C; Vogelzang, Nj; Sternberg, Cn; Szczylik, C; Zolnierek, J; Kollmannsberger, C; Rha, Sy; Bjarnason, Ga; Melichar, B; De Giorgi, U; Grünwald, V; Davis, Id; Lee, Jl; Esteban, E; Urbanowitz, G; Cai, C; Squires, M; Marker, M; Shi, Mm; Escudier, B. | |
| Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual? | 1-gen-2008 | De Giorgi, U; Perkins, Gh; Cristofanilli, M. | |
| Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7 | 1-gen-2018 | De Giorgi, U; Conteduca, V; Scarpi, E | |
| A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity | 1-gen-2001 | Bacci, G; Ferrari, S; Tienghi, A; Bertoni, F; Mercuri, M; Longhi, A; Fiorentini, G; Forni, C; Bacchini, P; Rimondini, S; De Giorgi, U; Picci, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 03 Articolo su Rivista38605
Data di pubblicazione
- In corso di stampa43
- 2020 - 202710433
- 2010 - 201913552
- 2000 - 20098692
- 1990 - 19993962
- 1980 - 19891442
- 1970 - 1979447
- 1961 - 196934
Editore
- Elsevier BV:PO Box 211, 1000 AE A...454
- American Institute of Physics:2 H...272
- Giuffre Editore Spa:via Busto Ars...128
- Elsevier Science Limited:Oxford F...99
- Congedo Editore Luogo pubbl. Gal...72
- IOP Publishing Limited:Dirac Hous...71
- Springer Verlag Germany:Tiergarte...71
- Kluwer Academic Publishers:Journa...54
- IEEE / Institute of Electrical an...47
- Societa Editrice il Mulino Spa:St...43
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS481
- THE EUROPEAN PHYSICAL JOURNAL. C,...393
- PHYSICS LETTERS. SECTION B392
- PHYSICAL REVIEW LETTERS211
- APPLIED PHYSICS LETTERS186
- NUCLEAR INSTRUMENTS AND METHODS I...185
- THE ASTROPHYSICAL JOURNAL180
- PHYSICAL REVIEW D, PARTICLES, FIE...156
- PHYSICAL REVIEW D148
- ITINERARI DI RICERCA STORICA140
Keyword
- ATLAS1158
- LHC1151
- High Energy Physics1130
- Humans376
- Mediterranean Sea185
- Italy177
- Female144
- Animals143
- Male127
- Hadron-Hadron Scattering122
Lingua
- eng25985
- ita9002
- fre415
- spa191
- ger146
- por94
- lat51
- grc47
- rus43
- chi13
Accesso al fulltext
- no fulltext32279
- open4081
- restricted1185
- reserved1012
- partially open32
- mixed10
- embargoed6